Rodrigo M. Ribeiro

Fortaleza, CE, Brazil

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature.

Deciphering the circadian signature in acute myeloid leukemia: NPAS2 downregulation as a master predictive feature.

Journal: Blood research
Published: February 28, 2026

Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic Variants.

Pharmacogenomics Applied to Acute Leukemias: Identifying Clinically Relevant Genetic Variants.

Journal: Biomedicines
Published: September 22, 2025

Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia.

Synergistic Effect of Antimicrobial Resistance and Cytogenetic Risk on Mortality in Acute Myeloid Leukemia.

Journal: Anticancer research
Published: April 16, 2025

WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT Expression.

WRAP53 is Downregulated in Acute Myeloid Leukemia Patients and Positively Correlates With HTERT Expression.

Journal: Cancer reports (Hoboken, N.J.)
Published: April 16, 2025

Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation.

Association of PARP1 Expression Levels and Clinical Parameters in Different Leukemic Subtypes With BCR::ABL1 p190+ Translocation.

Journal: Cancer diagnosis & prognosis
Published: May 22, 2024

Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.

Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.

Journal: Anticancer research
Published: April 08, 2024

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Molecular and Clinical Insights in the Increasing Detection of BCR::ABL1 p190+ in Adult Acute Myeloid Leukemia Patients.

Journal: In vivo (Athens, Greece)
Published: March 06, 2024

Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.

Validation of Endogenous Control Genes by Real-Time Quantitative Reverse Transcriptase Polymerase Chain Reaction for Acute Leukemia Gene Expression Studies.

Journal: Genes
Published: December 07, 2023

Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.

Journal: Cancer diagnosis & prognosis
Published: October 15, 2023

PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.

PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.

Journal: Cancers
Published: October 05, 2023

Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia.

Association between Immunophenotypic Parameters and Molecular Alterations in Acute Myeloid Leukemia.

Journal: Biomedicines
Published: February 15, 2023

Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives.

Kinase Inhibition in Multiple Myeloma: Current Scenario and Clinical Perspectives.

Journal: Pharmaceutics
Published: July 21, 2022
Showing 1-12 of 18

Last Updated: 09/26/2026